Hamdan Medical Journal (previously the Journal of Medical Sciences)
|Table of Contents|
Neonatal Sepsis in the Very Low Birth Weight Preterm Infants: Part 2: Review of Definition, Diagnosis and Management
Background: Having presented brief epidemiology of neonatal infection and patho-physiology of neonatal sepsis in the first part of this review we now address the difficulties in defining, diagnosing and treating neonatal sepsis.
Objective: The objective of this part of the review is firstly, to highlight the reasons for lack of consensus on the definition of neonatal sepsis despite a number of international conferences of experts on the subject. Secondly, to discuss the increasing sophistication of available laboratory tests and why they all lack the certainty desired by the clinician and thirdly to discuss the various evidence based treatment modalities available to treat neonatal sepsis.
Conclusion: It is suggested that pragmatic definition of sepsis as suggested by us should be adopted. Greater use of biomarkers and molecular tests should be made to diagnose sepsis early and accurately. Lastly, it is hoped to change the clinician’s paradigm by using evidence based management care bundle/package that includes adjunctive immune-modulatory and host defence boosting drugs.
Webster, 9th New Colligiate English Dictionary, Springfield, Merriman 1991.
Carcillo JA. Searching for aetiology of systemic inflammatory response syndrome: Is SIRS occult endotoxemia? Intens Care Med 2006; 134: 181-4.
Haque KN. Defining infections in children and neonates. J Hosp Infect 2005; 65(Suppl 2): 110-4.
Haque KN. Definitions of blood stream infections in the newborn. Pediatr Crit Care Med 2005; 6(Suppl): S45-9.
Haque KN. Understanding and optimising outcome in neonates with sepsis and septic shock. In: Vincent JL, Ed. Year book of Intensive Care and Emergency Medicine. Springer 2007; pp. 55-68.
Haque KN, Khan MA, Kerry S, Stephenson J, Woods G. Pattern of culture-proven neonatal sepsis in a district general hospital in the United Kingdom. Infect Control Hosp Epidemiol 2004; 25: 759-64.
Fischer JE. Physician’s ability to diagnose sepsis in the newborn and critically ill children. Pediatr Crit Care Med 2005; 6(Suppl): S120-5.
Goldstein B. Heart rate characteristics in neonatal sepsis: A promising test that is still premature. Pediatrics 2005; 115: 1070-2.
Radetsky M. The newborn at risk of serious infection. Clin Perinatol 1998; 25: 327-34.
Fanaroff AA, Korones SB, Wright LL, Verter J, Poland RL, Bauer CR, et al. Incidence, presenting features,risk factors and significance of late onset septicaemia in very low birth weight infants. The National Institute of Child Health and Human Development Neonatal Research Network. Pediatr Infect Dis J 1998; 17: 593-8.
Orr PA, Case KO, Stevenson JJ. Metabolic response and parenteral nutrition in trauma, sepsis and burns. J Infus Nurs 2002; 25: 45-53.
Mishra UK, Jacobs SE, Doyle LW, Garland SM.Newer approaches to the diagnosis of early onset neonatal sepsis. Arch Dis Child Fetal Neonatal Ed 2006; 91: F208-12.
Ng PC, Lam HS. Diagnostic markers for neonatal sepsis. Curr Opin Pediatr 2006; 18:125-31.
Spanjaard L, Kuijper EJ, Dankert J. Clinical comparison of two commercial blood culture systems. Eur J Clin Microbiol Infect Dis 2000; 19: 881-5.
Schelonka RL, Chai MK, Yoder BA, Hensley D,Brockett RM, Ascher DP. Volume of blood required to detect common neonatal pathogens. J Peadiatr 1996; 129: 275-8.
Sarkar S, Bhagat I, DeCristofaro JD, Wiswell TE, Spitzer AR. A study of the role of multiple site blood culture in the evaluation of neonatal sepsis. J Perinatol 2006; 26: 18-22.
DaSilva O, Ohlsson A, Kenyon C. Accuracy of leukocyte indices and C- reactive protein for the diagnosis of neonatal sepsis: a critical review. Pediatr Infect Dis J 1995; 14: 362-6.
Blommendahl J, Janas M, Laine S, Miettinen A, Ashorn P. Comparison of prolactin with CRP and differential white blood cell count for diagnosis of culture proven neonatal sepsis. Scand J Infect Dis 2002; 34: 620-2.
Benitz WE, Han MY, Madan A, Ramachandra P. Serial serum C-reactive protein levels in the diagnosis of neonatal infection. Pediatrics 1998;102: e41.
Døllner H, Vatten L, Austgulen R. Early diagnostic markers for neonatal sepsis: comparing C-reactive protein, interleukin-6, tumour necrosis factor receptors and adhesion molecules. J Clin Epidemiol 2001; 54: 1251-7.
Haque KN, Zaidi MH, Haque SK. Evaluation of Creactive protein by latex agglutination in neonatal sepsis. Pak Paed J 1986; 10: 229-33.
Couto RC, Barbosa JA, Pedrosa TM, Biscione FM.C-reactive protein guided approach may shorten length of antimicrobial treatment of culture-proven late onset sepsis: an intervention study. Braz J Infect Dis 2007; 11: 240-5.
Assumma M, Signore F, Pacifico L, Rossi N, Osborn JF, Chiesa C. Serum procalcitonin concentrations in term delivering mothers and their healthy offspring: a longitudinal study. Clin Chem 2000; 46:1583-7.
López Sastre JB, Pérez Solís D, Roqués Serradilla V, Fernández Colomer B, Coto Cotallo GD, Krauel Vidal X, et al. Procalcitonin is not sufficiently reliable to be the sole marker of neonatal sepsis of nosocomial origin. BMC Pediatr 2006; 6: 16.
Turner D, Hammerman C, Rudensky B, Schlesinger Y, Schimmel MS. The role of procalcitonin as a predictor of nosocomial sepsis in preterm infants. Acta Pediatr 2006; 95: 1571-6.
Stocker M, Fontana M, El Helou S, Wegscheider K, Berger TM. Use of Procalcitonin-Guided decisionmaking to shorten antibiotic therapy in suspected neonatal EOS: prospective, randomized intervention trial. Neonatology 2009; 97: 165-74.
Baek YW, Brokat S, Padbury JF, Pinar H, Hixson DC,Lim YP. Inter-alpha inhibitor proteins in infants and decreased levels in neonatal sepsis. J Pediatr 2003; 143: 11-5.
Arnon S, Litmanovitz I, Regev RH, Bauer S, Shainkin- Kestenbaum R, Dolfin T. Serum Amyloid A: an early and accurate marker of neonatal early onset sepsis. J Perinatol 2007; 27: 297-302.
Arnon S, Limanovitz I. Diagnostic tests in neonatal sepsis. Curr Opin Infect Dis 2008; 21: 223-7.
Küster H, Weiss M, Willeitner AE, Detlefsen S, Jeremias I, Zbojan J, et al. Interleukin-1 receptor antagonist and interleukin-6 for early diagnosis of neonatal sepsis two days before clinical manifestation. Lancet 1998; 352: 1271-7.
Oberholzer A, Oberholzer C, Moldawer LL. Interleukin 10: a complex role in the pathogenesis of sepsis syndrome and its potential as an antiinflammatory drug. Crit Care Med 2002; 30: S58-S63.
Ng PC, Li K, Leung TF, Wong RP, Li G, Chui KM, et al. Early prediction of sepsis induced disseminated intravascular coagulation with interleukin-10,interleukin-6 and RANTES in preterm infants. Clin Chem 2006; 52: 1181-9.
Jordan JA, Durso MB. Real-time polymerase chain reaction for detecting bacterial DNA directly from blood of neonates being evaluated for sepsis. J Mol Diagn 2005; 7: 575-81.
Shang S, Chen G, Wu Y, DU L, Zhao Z. Rapid diagnosis of bacterial sepsis with PCR amplification and micro array hybridization in 16SrRNA gene.Pediatr Res 2005; 58: 143-8.
Gibot S, Cravoisy A. Soluble form of triggering receptor expressed on myeloid cell-1 as a marker of microbial infection. Clin Med Res 2004; 2: 181-7.
Blanco A, Solis G, Arranz E, Coto GD, Ramos A,Telleria J. Serum levels of CD14 in neonatal sepsis with Gram-positive and Gram-negative bacteria. Acta Pediatr 1996; 85: 728-32.
Ng PC, Li G, Chui KM, Chu WC, Li K, Wong RP, et al. Neutrophil CD64 expression: a sensitive diagnostic marker for early onset neonatal infection. Pediatr Res 2004; 56: 796-803.
Ng PC. Diagnostic markers of infection in neonates. Arch Dis Child Fetal Neonatal Ed 2004;89: F229-35.
Vesser VE, Hall RT. Urine culture in the evaluation of suspected neonatal sepsis. J Pediatr 1979; 94: 635-8.
DiGeronimo RJ. Lack of efficacy of urine culture as part of initial work up of suspected neonatal sepsis. Pediatr Infect Dis J 1992; 11: 764-6.
Sánchez PJ, Siegel JD, Cushion NB, Threlkeld N.Significance of a positive urine group B streptococcal latex test in neonates. J Pediatr 1990; 116: 601-6.
Haque KN. Infection and Immunity in the newborn.In: McIntosh N, Helms P, Eds. Textbook of Paediatrics. 6th edition. Churchill Livingstone: Edinburgh 2003; pp. 273-90.
Garges HP, Moody MA, Cotten CM, Smith PB,Tiffany KF, Lenfestey R, et al. Neonatal meningitis: What is the correlation among cerebrospinal fluid cultures, blood cultures and cerebrospinal fluid parameters? Pediatrics 2006; 11: 1094-100.
Wiswell TE, Baumgart S, Gannon CM, Spitzer AR. No lumbar puncture in the evaluation for early neonatal sepsis: will meningitis be missed? Pediatr 1995; 95: 803-6.
MacMohan P, Jewes L, deLouvois J. Routine lumbar punctures in the newborn- -are they justified? Eur J Pediatr 1990; 149: 797-9.
Darmstadt GL, Saha SK, Ahmed AS, Ahmed S,Chowdhury MA, Law PA, et al. Effects of skin barrier therapy on neonatal mortality rates in preterm infants in Bangladesh: a randomized, controlled, clinical trial. Pediatrics 2008; 121: 522-9.
Benitz W, Gould JB, Druzin ML. Antimicrobial prevention of early onset GBS sepsis: Estimates of risk reduction based on critical literature review. Pediatrics 2000; 106: 377-378.
Kenyon S, Boulvain M, Neilson J. Antibiotics for preterm rupture of membranes: a systematic review. Obstet Gynecol 2004; 104: 1051-7.
Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, et al. Late onset sepsis in very low birth weight neonates: the experience of NICHD Neonatal Research Network. Pediatrics 2002; 110: 285-91.
Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, et al. Changes in pathogens causing early-onset sepsis in very low birth weight infants. N Engl J Med 2002; 347: 240-7.
Kumar A, Roberts D, Wood KE, Light B, Parrillo JE,Sharma S, et al. Duration of hypotension before initiation of antimicrobial therapy is critical determinant of survival in human septic shock. Crit Care Med 2006; 34: 1589-96.
Mtitimila EI, Cook RWI. Antibiotic regimens for suspected early neonatal sepsis. Cochrane Library 2004; Issue 4.
Gordon A, Jeffery HE. Antibiotic regimens for suspected late onset sepsis in newborn infants. Cochrane Data Syst Rev 2005; Issue 3. Art No: CD 004501. DOI:10:1002/14651858.CD004501.pub2.
Calil R, Marba ST, von Nowakonski A, Tresoldi AT.Reduction in colonisation and nosocomial infection by multi-resistant bacteria in a neonatal unit after institution of educational measures and restriction in the use of cephalosporins. Am J Infect Control 2001; 29: 133-8.
Stoll BJ, Hansen NI, Higgins RD, Fanaroff AA, Duara S, Goldberg R. Very low birth weight preterm infants with early onset neonatal sepsis: the predominance of Gram-negative infections continues in the National Institute of Childhealth and Human development Neonatal Research Network. 2002-2003. Pediatr Infect Dis J 2005; 24:635-9.
Capparelli E, Hochwald C, Rasmussen M, Parham A, Bradley J, Moya F. Population pharmacokinetics of cefepime in the neonate. Antimicrob AgentsChemother 2005; 49: 2760-6.
American Academy of Pediatrics. Table -4 of antibacterial drug dosages. In: Pickering L, Ed.Report of the committee on Infectious Diseases. American Academy of Paediatrics: Elk Grove Village, Il, 2003; pp. 700-1.
Constantopolous A, Thomaidou L, Loupa H,Papoulias G. Successful response of severe neonatal gram-negative infection to treatment with aztreonam. Chemotherapy 1989; 35(Suppl 1):101-5.
Cuzzolin L, Fanos V, Zambreri D, Padovani EM,Benoni G. Pharmacokinetics and renal tolerance of aztreonam in premature infants. Antimicrob Agents Chemother 1991; 35: 1726-8.
Haque KN. Diagnosis and treatment of neonatal sepsis: Is it evidence based? Results of a nationwide survey. J Clin Excellence 2000; 2: 33-8.
Philips AGS. The changing face of neonatal infections: Experience at a regional medical centre. Pediatr Infect Dis J 1994; 13: 1098-102.
O'Neill P, Heath Jr CW, Shann F, Henry DA, Hilton-Jones D, Squier MV. How long to treat bacterial meningitis? Lancet 1993; 341: 530-1.
Graham PL 3rd, Begg MD, Larson E, Della-Latta P, Allen A, Saiman L. Risk factors for late onset Gramnegative sepsis in low birth weight infants hospitalised in intensive care units. Pediatr Infect Dis J 2006; 25: 113-7.
Pourcyrous M, Bada HS, Korones SB, Baselski V, Wong SP. Significance of serial C - reactive protein response in neonatal infections and other disorders. Pediatrics 1993; 92: 431-5.
Ehl S, Gering B, Bartmann P, Högel J, Pohlandt F. Creactive protein is a useful marker for guiding duration of antibiotic therapy in suspected neonatal bacterial infection. Pediatrics 1997; 99: 216-21.
Engle WD, Jackson GL, Sendelbach DM, Stehel EK,Ford DM, McHugh KM, et al. Pneumonia in term neonates, laboratory studies and duration of antibiotic therapy. J Perinatol 2003; 23: 372-7.
Labenne M, Michaut F, Gouyon B, Ferdynus C,Gouyon JB. A population based observation study of restrictive guidelines of antibiotic therapy in early onset neonatal infection. Pediatr Infect Dis J 2007; 26: 593-9.
Ceroni D, Regusci M, Pazos JM, Saunders CT, Kaelin A. Risks and complications of prolonged parenteral antibiotic treatment in children with acute osteoarticular infections. Acta Orthop Belg 2003;69: 400-4.
Baker ADL, Macnicol MF. Haematogenous Osteomyelitis: epidemiology, classification, aetiology and treatment. Paediatr Child Health 2008; 18(2): 75-84.
Craft AP, Finer NN, Barrington KJ. Vancomycin for prophylaxis against sepsis in preterm neonates.Cochrane Database Syst Rev 2000; (2) CD 001971.
Mohan P, Broklehurst P. Granulocyte transfusion for neonates with confirmed or suspected sepsis and neutropenia. Cochrane Database Syst Rev 2003;Issue 4: CD 003956.
Carr R, Modi N, Dore C. G-CSF and GM-CSF for treating or preventing neonatal infections. Cochrane Database Syst Rev 2003; Issue 3: CD 003066.
Marshall JC. Such stuff as dreams are made on:mediator directed therapy in sepsis. Nat Rev Drug Discov 2003; 2: 391-405.
Riedmann NC, Guo RF, Ward PA. Novel strategies for the treatment of sepsis. Nat Med 2003; 9: 517-24.
Hotckiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348: 138-50.
Haque KN, Mohan P. Pentoxifylline for neonatal sepsis. Cochrane Database Syst Rev 2003; Issue 4:CD 004205.
Bayry J, Lacroix-Desmazes S, Kazatchkine MD,Kaveri SV. Intravenous immunoglobulin for infectious diseases: back to pre-antibiotic and passive prophylaxis era. Trends Pharmacol Sci 2004;25: 306-10.
Laupland KB, Kirkpatrick AW, Delaney A. Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: A systematic review and meta-analysis. Crit Care Med 2007; 35: 2686-92.
Kazatchkine MD, Kaveri SV. Immunomodulation of autoimmune and inflammatory disease with intravenous immunoglobulin. N Engl J Med 2001;345: 747-55.
Andersson J, Skansén-Saphir U, Sparrelid E,Andersson U. Intravenous Immunoglobulin affects cytokine production in T lymphocytes and monocytes/macrophages. Clin Exp Immunol 1996;104(Suppl.1): 10-20.
Aukrust P, Müller F, Svenson M, Nordøy I, Bendtzen K, Frøland SS. Administration of intravenous immunoglobulin (IVIG) in vivo down regulatory effects of the IL-1 system. Clin Exp Immunol 1999;115: 136-43.
Ross C, Svenson M, Hansen MB, Vejlsgaard GL, Bendtzen K. High avidity IFN-neutralizing antibodies in pharmaceutically prepared IgG. J Clin Invest 1995; 95: 1974-8.
Stangel M, Schumacher HC, Ruprecht K, Boegner F, Marx P. Immunoglobulin for intravenous use inhibit TNFa cytotoxicity in vitro. Immunol Invest 1997; 26: 569-78.
Kondo N, Kasahara K, Kameyama T, Suzuki Y, Shimozawa N, Tomatsu S, et al. Intravenous immunoglobulins suppress immunoglobulin production by suppressing Ca2B lymphocytes. Scand J Immunol 1994; 40: 37-42.
Kaveri S, Vassilev T, Hurez V, Lengagne R, Lefranc C, Cot S, et al. Antibodies to a conserved to a region of HLA class I molecule, capable of modulating CD8 T cell mediated function are present in pooled normal immunoglobulin for therapeutic use. J Clin Invest 1996; 97: 865-9.
Teeling JL, De Groot ER, Eerenberg AJ, Bleeker WK,Van Mierlo G, Aarden LA, et al. Human Intravenous Immunoglobulin (IVIG) preparations degranulate human neutrophils in vitro. Clin Exp Immunol 1998;114: 264-70.
Lutz HU, Stammler P, Jelezarova E, Nater M, Späth PJ. High doses of immunoglobulin G attenuate aggregate mediated complement activation by enhancing physiological cleavage of C3b in C3bn-IgG complexes. Blood 1996; 88: 184-93.
Ohlsson A, Lacey JB. Intravenous immunoglobulin for suspected or subsequently proven infection in neonates. Cochrane Database Syst Rev 2002; Issue1: CD 001239.
Norrby-Teglund A, Haque KN, Hammarström L.Intravenous polyclonal IgM enriched immunoglobulin therapy in sepsis: a review of clinical efficacy in relation to microbiological aetiology and severity of sepsis. J Intern Med 2006;260: 509-16.
Kreymann KG, de Heer G, Nierhaus A, Kluge S. Use of polyclonal immunoglobulin’s as adjunctive therapy for sepsis or septic shock. Crit Care Med 2007; 35: 2677-85.
Manzoni P, Rinaldi M, Cattani S, Pugni L, Romeo MG, Messner H, et al. Bovine Lactoferrin Supplementation for Prevention of Late-Onset Sepsis in Very Low- Birth Weight Neonates: A randomized Trial. JAMA 2009; 302: 1421-8.
Osborne DA, Evans N. Early volume expansion for prevention of morbidity and mortality in very preterm infants. Cochrane Database Syst Rev 2004; Issue 4 CD 00205.
Subedhar NV, Shaw NJ. Dopamine versus dobutamine for hypotensive preterm infants.Cochrane Database Syst Rev 2003; Issue 3: CD 001241.
Lawn CJ, Weir FJ, McGuire W. Base administration or fluid bolus for preventing morbidity and mortality in preterm infants with metabolic acidosis. Cochrane Database Syst Rev 2005; Issue 2: CD 003215.
Wildhaber BE, Yang H, Spencer AU, Drongowski RA, Teitelbaum DH. Lack of enteral nutrition – effects on intestinal immune system. J Surg Res 2005; 123:8-16.
Infection Control in NICU: Guidelines for perinatal care, 4th ed. American Academy of Paediatrics and American College of Obstetricians andGynecologists 2001. CDC:http:/www.cdc.gov.htm.